DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Y-mAbs Announces GPA33-SADA Data Presented at AACR 12 April 2021

Press Release NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more

Introducing New Products and Initiatives by EBD Group 23 March 2021

We are excited to share with you EBD’ new products and initiatives that are being launched this month. Startup... Read more

2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint 01 March 2021

Press Release 2cureX announced today that its prospective interventional clinical trial investigating... Read more

Y-mAbs Announces 2020 Financial Results and Recent Corporate Developments 25 February 2021

Press Release NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more

Y-mAbs Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares 22 February 2021

Press Release NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more

Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora® Cream for Treatment of Plaque Psoriasis 17 February 2021

PRESS RELEASE In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque... Read more

Y-mAbs Announces Proposed Public Offering of Common Stock 16 February 2021

PRESS RELEASE NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more

A great milestone reached in the Gedea Biotech’s NEFERTITI Clinical Trial of pHyph for antibiotic-free treatment of women with bacterial vaginosis 02 February 2021

LINK Medical, the Northern European clinical research organization (CRO), and the Swedish women’s health... Read more

2cureX appoints Kenneth Graabek Johansen, an experienced business and financial executive, as new CFO 28 January 2021

2cureX is pleased to announce that Kenneth Graabek Johansen has been appointed new CFO and will start... Read more

Copyright 2021 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design